Skip to content

Objective Testing of Tear Film Stability

Objective Testing of Tear Film Stability

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00789529
Enrollment
32
Registered
2008-11-13
Start date
2008-09-30
Completion date
2008-11-30
Last updated
2013-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contact Lens Solutions

Keywords

Contact lenses, wettability, Contact Lens Disinfectant Solutions, pre-lens tear film

Brief summary

The purpose of this study is to evaluate the in-vivo wettability of soft contact lenses when cared with two different multi-purpose solutions over a two week wearing period.

Interventions

soft contact lens disinfecting solution

DEVICEReNu MultiPlus®

soft contact lens disinfecting solution

Sponsors

Alcon Research
CollaboratorINDUSTRY
Manhattan Vision Associates
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

1. The subject must be at least 18 years of age and no more than 80 years of age. 2. The subject must have a best corrected visual acuity of 20/30 or better for each eye. 3. The subject must habitually wear contact lenses. 4. The subject must have had an eye exam within the last 12 months. The exam data must be available to the investigators prior to the first visit. 5. The subject must have normal eyes, no use of ocular medications, no ocular infection of any type, and no ocular inflammation. 6. The subject must read understand and sign the Statement of Informed Consent. 7. The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.

Exclusion criteria

1. Ocular or systemic allergies or disease that might interfere with contact lens wear. 2. Systemic disease, autoimmune disease or use of medication which might interfere with contact lens wear. 3. Clinically significant (FDA Scale grade 3 or 4) corneal edema, corneal vascularization, corneal staining or any other abnormalities of the cornea which would contraindicate contact lens wear. 4. Clinically significant (FDA Scale grade 3 or 4) tarsal abnormalities or bulbar injection which might interfere with contact lens wear. 5. Any ocular infection. 6. Pregnancy or lactation. 7. Diabetes 8. Infectious diseases (e.g. hepatitis, tuberculosis) 9. Contagious immunosuppressive diseases (e.g. HIV)

Design outcomes

Primary

MeasureTime frameDescription
Objective, In-vivo Soft Contact Lens Wettability Index2 weeksThe wettability index is derived from the slope of a metric developed to measure the regularity of the Shack-Hartmann wavefront sensor image. The more wettable a lens is the more stable the metric and the slope of the metric (the wettability index) is closer to zero. The more negative values indicate a less wettable the lens.

Secondary

MeasureTime frameDescription
Subject Questionnaire Response2 weeksSubject questionnaire response: Overall comfort at 2 weeks in a 0-50 point scale. 0=Very poor 50 = Excellent

Countries

United States

Participant flow

Recruitment details

Recruitment of patients was conducted by approaching the patients seen in the practice.

Pre-assignment details

32 subjects were recruited and enrolled in the study. No subjects had to be excluded.

Participants by arm

ArmCount
1 - ReNu MultiPlus First
Used ReNu MultiPlus first, Opti-Free RepleniSH Second
16
2 - Opti-Free RepleniSH First
Opti-Free RepleniSH first, ReNu MultiPlus Second
16
Total32

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyOther Reason10
Overall StudyWithdrawal by Subject01

Baseline characteristics

Characteristic2 - Opti-Free RepleniSH First1 - ReNu MultiPlus FirstTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
16 Participants16 Participants32 Participants
Age Continuous27.4 years
STANDARD_DEVIATION 5.1
27.3 years
STANDARD_DEVIATION 3.8
27.3 years
STANDARD_DEVIATION 4.4
Region of Enrollment
United States
16 participants16 participants32 participants
Sex: Female, Male
Female
14 Participants13 Participants27 Participants
Sex: Female, Male
Male
2 Participants3 Participants5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 160 / 16
serious
Total, serious adverse events
0 / 160 / 16

Outcome results

Primary

Objective, In-vivo Soft Contact Lens Wettability Index

The wettability index is derived from the slope of a metric developed to measure the regularity of the Shack-Hartmann wavefront sensor image. The more wettable a lens is the more stable the metric and the slope of the metric (the wettability index) is closer to zero. The more negative values indicate a less wettable the lens.

Time frame: 2 weeks

Population: Per protocol. All participants that completed both arms were analysed.

ArmMeasureValue (MEAN)Dispersion
Opti-Free® RepleniSH® MPDSObjective, In-vivo Soft Contact Lens Wettability Index-1.82 wettability indexStandard Deviation 2.88
Renu MultiPlus®Objective, In-vivo Soft Contact Lens Wettability Index-1.98 wettability indexStandard Deviation 2.8
Secondary

Subject Questionnaire Response

Subject questionnaire response: Overall comfort at 2 weeks in a 0-50 point scale. 0=Very poor 50 = Excellent

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Opti-Free® RepleniSH® MPDSSubject Questionnaire Response42.7 units on a scaleStandard Deviation 7.3
Renu MultiPlus®Subject Questionnaire Response43.1 units on a scaleStandard Deviation 5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026